,
,
, , p.912
, A. Riondel (TransVIHMI
, UCAC
,
,
,
,
,
, Hôpital Général
,
, District Hospital
, District Hospital
,
, Mbalmayo
, Bikop
,
,
, Catholic Hospital
, Ngam Engonwei (District Hospital
, Issiakou Adamou, G.Temgoua (District Hospital
, District Hospital
, District Hospital
,
, World Health Organization. Global health sector strategy on viral hepatitis 2016-2021: towards ending viral hepatitis, 2016.
Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets, Lancet Gastroenterol Hepatol, vol.2, pp.900-909, 2017. ,
, World Health Organization. Global hepatitis report, 2017.
Global burden of hepatitis B infection in people living with HIV: a systematic review and meta-analysis, Clin Infect Dis, 2019. ,
, Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach, 2010.
, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach, 2016.
, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2013.
Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa, BMC Infect Dis, vol.17, p.706, 2017. ,
Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon, Antivir Ther, vol.17, pp.321-327, 2012. ,
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in the Gambia, BMC Res Notes, vol.4, p.561, 2011. ,
High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy, HIV Med, vol.11, pp.85-94, 2010. ,
High prevalence of hepatitis B and syphilis co-infections among HIV patients initiating antiretroviral therapy in the north-west region of Cameroon, Int J STD AIDS, vol.23, pp.435-443, 2012. ,
Sero-prevalence of HBsAg in naive HIV-infected patients in a rural locality of Cameroon, BMC Res Notes, vol.11, p.39, 2018. ,
, Directives nationales de prise en charge par les antirétroviraux des personnes (adultes et adolescents) infectées par le VIH. Yaoundé, 2010.
Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM), HIV Med, vol.20, pp.38-46, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02456788
Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon, AIDS, vol.24, issue.1, pp.5-15, 2010. ,
Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis, PLoS One, vol.8, p.68152, 2013. ,
Hepatitis B virus infection, Lancet, vol.384, pp.2053-63, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02370703
Clinical implications of HIV and hepatitis B coinfection in Asia and Africa, Lancet Infect Dis, vol.7, pp.402-411, 2007. ,
Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden, J Viral Hepat, vol.16, pp.453-63, 2009. ,
, Ministry of Public Health. National guideline on the prevention and management of HIV in Cameroon, 2015.
Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes, PLoS One, vol.12, p.179025, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01570239
Implementation of routine screening for chronic hepatitis B virus co-infection by HIV clinics in Lusaka, Zambia, J Viral Hepat, vol.22, pp.858-60, 2015. ,
Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection, AIDS, vol.22, pp.152-156, 2008. ,
Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine, Clin Infect Dis, vol.28, pp.1032-1037, 1999. ,
, World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection, 2015.
High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa, J Clin Virol, vol.35, pp.14-20, 2006. ,
High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana, Open Forum Infect Dis, vol.4, p.195, 2017. ,
Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/ Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana, Open Forum Infect Dis, vol.3, p.140, 2016. ,
Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV Coinfection in Zambia, Clin Infect Dis, vol.64, pp.1343-1352, 2017. ,
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations